A Post-marketing Study Evaluating Eslicarbazepine Acetate (ESL) as Adjunctive Treatment in Partial-Onset Seizures (Study E2093-E044-404) (EPOS)

NCT01830400 · clinicaltrials.gov ↗

COMPLETED

Status

254

Enrollment

INDUSTRY

Sponsor class

Conditions

Partial Onset Seizures

Interventions

DRUG: Eslicarbazepine Acetate tablets

Sponsor

Eisai Inc.